Edgestream Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-27,349
Closed -$1.29M 951
2023
Q2
$1.29M Buy
+27,349
New +$1.29M 0.12% 303